Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (8217)	9/30/1999 3:22:00 PM
From: Anthony Wong	Respond to of 9523

CELEBREX(TM) Named 'Best Branded Pharmaceutical Product' news.com

To: Brander who wrote (8217)	9/30/1999 3:25:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

RESEARCH ALERT-Schroders details drug coverage biz.yahoo.com Ecxcerpts: Excerpts: NEW YORK, Sept 30 (Reuters) - Schroders Securities on Thursday gave details on its start of coverage of five pharmaceutical companies. -- It added to its recommended list Bristol-Myers Squibb Co. (NYSE:BMY - news), Pfizer Inc. (NYSE:PFE - news) and Warner-Lambert Co. (NYSE:WLA - news) at outperform significantly. Pfizer: -- Set price target of $48. -- Said expects Pfizer to post annualized EPS growth of about 20 percent from 1998 to 2003. -- Said Pfizer is ''fundamentally best-positioned company in the industry.'' Shares of Pfizer were at 34-3/4, up 11/16, in Thursday morning trade.